ET,Jan. 12, 2015. About CAR T Immunotherapies Kite Pharma'sbroadly enabling eACT™ technology platform allows a patient's T cells to be modified to express cancer-targeting receptors genetically. Manufactured CAR T cells contain a one chain antibody domain, which recognizes and binds to a cell surface tumor antigen, in addition to intracellular T cell-activating domains. CAR T cells are made to traffic directly to tumor sites and be activated upon engagement with the target tumor antigen, selectively eradicating the tumor cells. AboutAmgen Amgenis committed to unlocking the potential of biology for individuals suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics.Ron Johnson that will require the CBO to statement the impact of the Affordable Health Care Act when it comes to employers dropping coverage . Boehner said that personalities and applicants -; not Republican proposals on spending and Medicare cuts -; accounted for the party's defeats, going for a hard series on further budget talks even as Senate Republicans met with President Obama in a search for common ground . That is part of Kaiser Health News' Daily Report – a summary of health policy from a lot more than 300 news organizations.